Yang Ni
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
-
- Lung Cancer Diagnosis and Treatment 10
- Lung Cancer Treatments and Mutations 5
- Medical Imaging and Pathology Studies 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Oncology 13
- Lung Cancer Research Studies 4
- Co-authors
- Xin Ye (26 shared papers)Guanghui Huang (31 shared papers)Min Meng (29 shared papers)Zhigang Wei (24 shared papers)Xiaoying Han (28 shared papers)Jiajun Du (6 shared papers)Wenhong Li (24 shared papers)Hongchang Shen (9 shared papers)
- Journals
- International Journal of Hyperthermia (8 papers)Scientific Reports (3 papers)European Radiology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yang Ni
84 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 115
- Hepatology 121
- Oncology 340
- Pulmonary and Respiratory Medicine 362
- Pharmaceutical Science 60
- Biological Psychiatry 21
Countries citing papers authored by Yang Ni
This map shows the geographic impact of Yang Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ni more than expected).
Fields of papers citing papers by Yang Ni
This network shows the impact of papers produced by Yang Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ni. The network helps show where Yang Ni may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 108 | |
| 2 | 2021 | 84 | |
| 3 | 2013 | 81 | |
| 4 | 2016 | 71 | |
| 5 | 2019 | 54 | |
| 6 | 2018 | 50 | |
| 7 | Tumor-stroma ratio is an independent predictor for survival in NSCLC. | 2015 | 48 |
| 8 | 2018 | 44 | |
| 9 | 2020 | 41 | |
| 10 | 2020 | 39 | |
| 11 | 2020 | 39 | |
| 12 | 2022 | 36 | |
| 13 | 2019 | 36 | |
| 14 | 2019 | 34 | |
| 15 | 2016 | 34 | |
| 16 | 2018 | 33 | |
| 17 | 2020 | 32 | |
| 18 | 2021 | 30 | |
| 19 | 2019 | 29 | |
| 20 | 2017 | 29 |
About Yang Ni
Yang Ni is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Hepatology and Organic Chemistry, having authored 89 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (4 papers), Medical Imaging and Pathology Studies (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer-related molecular mechanisms research (3 papers) and Sulfur-Based Synthesis Techniques (3 papers). The work is most often cited by research in Hepatology (121 citations), Oncology (340 citations), Pulmonary and Respiratory Medicine (362 citations), Pharmaceutical Science (60 citations) and Biological Psychiatry (21 citations). Yang Ni has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xin Ye, Guanghui Huang, Min Meng, Zhigang Wei, Xiaoying Han, Jiajun Du, Wenhong Li, Hongchang Shen, Xia Yang and Tiehong Zhang. Their work appears in journals such as International Journal of Hyperthermia, Scientific Reports, European Radiology, Journal of Cancer Research and Clinical Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.